Deschatelets Pascal Insider Trading
Get the latest insider transactions of Deschatelets Pascal. Deschatelets Pascal is Chief Operating Officer in Apellis Pharmaceuticals, Inc. ($APLS) and Chief Scientific Officer in Apellis Pharmaceuticals, Inc. ($APLS). Discover the current value of Deschatelets Pascal shares.
Address: C/O APELLIS PHARMACEUTICALS, INC. 6400 WESTWIND WAY, SUITE A CRESTWOOD 40014KY
Deschatelets Pascal is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
APLS | Apellis Pharmaceuticals, Inc. | Chief Scientific Officer, Chief Operating Officer | 875,837 |
Insider Trading Transactions of Deschatelets Pascal
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
Jun 25 2021 | APLS | Apellis Pharmaceuticals, ... | Deschatelets Pascal | Chief Scientific Offi ... | Buy | 2.67 | 6,250 | 16,688 | 875,837 |
Jun 25 2021 | APLS | Apellis Pharmaceuticals, ... | Deschatelets Pascal | Chief Scientific Offi ... | Sell | 65.61 | 6,250 | 410,063 | 869,587 |
Jun 25 2021 | APLS | Apellis Pharmaceuticals, ... | Deschatelets Pascal | Chief Scientific Offi ... | Option Exercise | 2.67 | 6,250 | 16,688 | 368,999 |
May 25 2021 | APLS | Apellis Pharmaceuticals, ... | Deschatelets Pascal | Chief Scientific Offi ... | Buy | 2.67 | 6,250 | 16,688 | 875,837 |
May 25 2021 | APLS | Apellis Pharmaceuticals, ... | Deschatelets Pascal | Chief Scientific Offi ... | Sell | 47.40 | 6,250 | 296,250 | 869,587 |
May 25 2021 | APLS | Apellis Pharmaceuticals, ... | Deschatelets Pascal | Chief Scientific Offi ... | Option Exercise | 2.67 | 6,250 | 16,688 | 375,249 |
Apr 29 2021 | APLS | Apellis Pharmaceuticals, ... | Deschatelets Pascal | Chief Scientific Offi ... | Buy | 2.67 | 4,500 | 12,015 | 869,587 |
Apr 29 2021 | APLS | Apellis Pharmaceuticals, ... | Deschatelets Pascal | Chief Scientific Offi ... | Option Exercise | 2.67 | 4,500 | 12,015 | 381,499 |
Apr 26 2021 | APLS | Apellis Pharmaceuticals, ... | Deschatelets Pascal | Chief Scientific Offi ... | Buy | 2.67 | 6,250 | 16,688 | 871,337 |
Apr 26 2021 | APLS | Apellis Pharmaceuticals, ... | Deschatelets Pascal | Chief Scientific Offi ... | Sell | 46.13 | 6,250 | 288,313 | 865,087 |
Apr 26 2021 | APLS | Apellis Pharmaceuticals, ... | Deschatelets Pascal | Chief Scientific Offi ... | Option Exercise | 2.67 | 6,250 | 16,688 | 385,999 |
Mar 11 2021 | APLS | Apellis Pharmaceuticals, ... | Deschatelets Pascal | Chief Scientific Offi ... | Buy | 2.67 | 6,250 | 16,688 | 871,337 |
Mar 11 2021 | APLS | Apellis Pharmaceuticals, ... | Deschatelets Pascal | Chief Scientific Offi ... | Sell | 50.74 | 6,250 | 317,125 | 865,087 |
Mar 11 2021 | APLS | Apellis Pharmaceuticals, ... | Deschatelets Pascal | Chief Scientific Offi ... | Option Exercise | 2.67 | 6,250 | 16,688 | 392,249 |
Feb 11 2021 | APLS | Apellis Pharmaceuticals, ... | Deschatelets Pascal | Chief Scientific Offi ... | Sell | 47.72 | 688 | 32,831 | 865,087 |
Feb 01 2021 | APLS | Apellis Pharmaceuticals, ... | Deschatelets Pascal | Chief Scientific Offi ... | Buy | 0.00 | 7,500 | 0 | 863,900 |
Feb 01 2021 | APLS | Apellis Pharmaceuticals, ... | Deschatelets Pascal | Chief Scientific Offi ... | Buy | 0.00 | 1,875 | 0 | 865,775 |
Feb 01 2021 | APLS | Apellis Pharmaceuticals, ... | Deschatelets Pascal | Chief Scientific Offi ... | Option Exercise | 44.90 | 45,000 | 2,020,500 | 45,000 |
Feb 01 2021 | APLS | Apellis Pharmaceuticals, ... | Deschatelets Pascal | Chief Scientific Offi ... | Option Exercise | 44.90 | 11,250 | 505,125 | 11,250 |
Mar 12 2020 | APLS | Apellis Pharmaceuticals, ... | Deschatelets Pascal | Chief Operating Offic ... | Sell | 0.00 | 161,656 | 0 | 847,025 |
Feb 14 2020 | APLS | Apellis Pharmaceuticals, ... | Deschatelets Pascal | Chief Operating Offic ... | Buy | 2.14 | 117,206 | 250,821 | 998,949 |
Feb 14 2020 | APLS | Apellis Pharmaceuticals, ... | Deschatelets Pascal | Chief Operating Offic ... | Sell | 42.80 | 52,075 | 2,228,966 | 946,874 |
Feb 14 2020 | APLS | Apellis Pharmaceuticals, ... | Deschatelets Pascal | Chief Operating Offic ... | Buy | 2.14 | 117,205 | 250,819 | 1,064,079 |
Feb 14 2020 | APLS | Apellis Pharmaceuticals, ... | Deschatelets Pascal | Chief Operating Offic ... | Sell | 40.98 | 55,398 | 2,270,155 | 1,008,681 |
Feb 14 2020 | APLS | Apellis Pharmaceuticals, ... | Deschatelets Pascal | Chief Operating Offic ... | Option Exercise | 2.14 | 117,206 | 250,821 | 117,205 |
Feb 14 2020 | APLS | Apellis Pharmaceuticals, ... | Deschatelets Pascal | Chief Operating Offic ... | Option Exercise | 2.14 | 117,205 | 250,819 | 0 |
Feb 12 2020 | APLS | Apellis Pharmaceuticals, ... | Deschatelets Pascal | Chief Operating Offic ... | Buy | 0.00 | 9,375 | 0 | 891,118 |
Feb 12 2020 | APLS | Apellis Pharmaceuticals, ... | Deschatelets Pascal | Chief Operating Offic ... | Option Exercise | 44.33 | 56,250 | 2,493,563 | 56,250 |
Sep 26 2019 | APLS | Apellis Pharmaceuticals, ... | Deschatelets Pascal | Chief Operating Offic ... | Sell | 25.24 | 20,531 | 518,161 | 882,753 |
Sep 26 2019 | APLS | Apellis Pharmaceuticals, ... | Deschatelets Pascal | Chief Operating Offic ... | Sell | 25.64 | 1,010 | 25,897 | 881,743 |
Sep 25 2019 | APLS | Apellis Pharmaceuticals, ... | Deschatelets Pascal | Chief Operating Offic ... | Sell | 25.07 | 20,758 | 520,362 | 924,986 |
Sep 25 2019 | APLS | Apellis Pharmaceuticals, ... | Deschatelets Pascal | Chief Operating Offic ... | Sell | 25.53 | 100 | 2,553 | 924,886 |
Sep 25 2019 | APLS | Apellis Pharmaceuticals, ... | Deschatelets Pascal | Chief Operating Offic ... | Sell | 24.56 | 20,307 | 498,760 | 904,579 |
Sep 25 2019 | APLS | Apellis Pharmaceuticals, ... | Deschatelets Pascal | Chief Operating Offic ... | Sell | 24.96 | 1,295 | 32,321 | 903,284 |
Feb 12 2019 | APLS | Apellis Pharmaceuticals, ... | Deschatelets Pascal | Chief Operating Offic ... | Option Exercise | 13.85 | 95,000 | 1,315,750 | 95,000 |
May 09 2018 | APLS | Apellis Pharmaceuticals, ... | Deschatelets Pascal | Chief Operating Offic ... | Buy | 0.00 | 384,292 | 0 | 945,744 |
Feb 21 2018 | APLS | Apellis Pharmaceuticals, ... | Deschatelets Pascal | Chief Operating Offic ... | Option Exercise | 14.95 | 110,000 | 1,644,500 | 110,000 |